Expect a legal battle before the US Food and Drug Administration’s proposed rule on lab-developed tests can be put into effect, a former FDA chief counsel told Medtech Insight.
Dan Troy, who is now a managing director specializing in the healthcare sector at Berkeley Research Group, was the FDA’s chief counsel from 2001-2004